Armenia vs Jordan: Previously treated cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Jordan
100.0%
in 2024
Armenia rank
1st
Jordan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Armenia
- Jordan
How they compare
Armenia currently reports 100.0% against 100.0% in Jordan, a difference of 0.0%.
The two have swapped places 8 times across 20 shared years of data; in 2005 it was Jordan ahead.
Armenia ranks 1st and Jordan ranks 1st of 180 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Jordan in 1.
Head to head by decade
| Decade | Armenia | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.4% | 87.0% | 42.6% | Jordan |
| 2010s | 39.7% | 36.5% | 3.2% | Armenia |
| 2020s | 98.4% | 58.4% | 40.0% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Armenia or Jordan?
- Armenia, at 100.0% against 100.0% in Jordan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Armenia and Jordan?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Jordan?
- 20 years are reported by both, from 2005 to 2024.
- How do Armenia and Jordan rank globally for previously treated cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Jordan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.